Get started
Author

Chu‐Yueh Guo

A pathogenic and clonally expanded B cell transcriptome in active multiple sclerosis
2020 · Akshaya Ramesh, Ryan D. Schubert, et al. · Proceedings of the National Academy of Sciences · 192
PDF
An autoantibody signature predictive for multiple sclerosis
2024 · Colin R. Zamecnik, Gavin M. Sowa, et al. · Nature Medicine · 91
PDF
Polygenic risk score association with multiple sclerosis susceptibility and phenotype in Europeans
2022 · Hengameh Shams, Xiaorong Shao, et al. · Brain · 68
PDF
Anti-gamma-aminobutyric acid receptor type A encephalitis: a review
2020 · Chu-Yueh Guo, Jeffrey M. Gelfand, et al. · Current Opinion in Neurology · 41
Specific hypomethylation programs underpin B cell activation in early multiple sclerosis
2021 · Qin Ma, Stacy J. Caillier, et al. · Proceedings of the National Academy of Sciences · 34
Transitioning From S1P Receptor Modulators to B Cell–Depleting Therapies in Multiple Sclerosis
2022 · William M. Rowles, Wan-Yu Hsu, et al. · Neurology Neuroimmunology & Neuroinflammation · 22
PDF
A Closed-Loop Falls Monitoring and Prevention App for Multiple Sclerosis Clinical Practice: Human-Centered Design of the Multiple Sclerosis Falls InsightTrack
2023 · Valerie J Block, Kanishka Koshal, et al. · JMIR Human Factors · 10
PDF
Remote Observational Research for Multiple Sclerosis
2022 · Riley Bove, Shane Poole, et al. · Neurology Neuroimmunology & Neuroinflammation · 10
PDF
Underutilization of physical therapy for symptomatic women with MS during and following pregnancy
2020 · Valerie J Block, Olivia Mestas, et al. · Multiple Sclerosis and Related Disorders · 9
Aspirin is an effective pretreatment for exercise in multiple sclerosis: A double-blind randomized controlled pilot trial
2017 · Victoria M Leavitt, Adam R Blanchard, et al. · Multiple Sclerosis Journal · 9
Neutropenia Associated With B Cell–Depleting Therapies in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
2025 · Greer Waldrop, Nikki Sisodia, et al. · Neurology Neuroimmunology & Neuroinflammation · 8
PDF
A Closed-Loop Digital Health Tool to Improve Depression Care in Multiple Sclerosis: Iterative Design and Cross-Sectional Pilot Randomized Controlled Trial and its Impact on Depression Care
2024 · Kyra Henderson, Jennifer Reihm, et al. · JMIR Formative Research · 7
PDF
HLA-A∗03:01 as predictive genetic biomarker for glatiramer acetate treatment response in multiple sclerosis: a retrospective cohort analysis
2025 · Brian C. Zhang, Tilman Schneider-Hohendorf, et al. · EBioMedicine · 6
Characteristics of multiple sclerosis and demyelinating disease in an Asian American population
2023 · Jessica H Fan, Jessa Alexander, et al. · Multiple Sclerosis Journal · 6
PDF
Autoimmune Encephalitis Consensus Criteria
2023 · Jeffrey M. Gelfand, Chu-Yueh Guo · Neurology Clinical Practice · 4
PDF
Actionable Wearables Data for the Neurology Clinic: A Proof‐of‐Concept Tool
2025 · Nicolette Miller, Ebenezer Chinedu‐Eneh, et al. · Annals of Clinical and Translational Neurology · 2
PDF
Real-world Treatment Outcomes in Black, Hispanic, Asian, and White People with Multiple Sclerosis Treated with Fumarates (P4-6.005)
2024 · Sophia Woodson, Edward Gettings, et al. · Neurology · 2
Pragmatic phase II clinical trial to improve depression care in a real-world diverse MS cohort from an academic MS centre in Northern California: MS CATCH study protocol
2024 · Kyra Henderson, Jennifer Reihm, et al. · BMJ Open · 2
PDF
Real-World Treatment Outcomes in Black, Hispanic, Asian, and White People with Multiple Sclerosis Treated with Fumarates in the USA
2025 · Sophia Woodson, Edward J. Gettings, et al. · Neurology and Therapy · 1
PDF
Large Language Models to Infer Depression in Patients with Neurological Conditions: Applications and Limitations (P2-1.006)
2025 · Maya Julian-Kwong, Shane Poole, et al. · Neurology · 1
A rare case of HIV CNS escape in a patient previously considered a viral controller
2020 · Jessica Magid-Bernstein, Chu-Yueh Guo, et al. · International Journal of STD & AIDS · 1
Persistent differences in initial diagnostic trajectory for Black and Hispanic individuals presenting with multiple sclerosis between 2020 and 2023
2026 · Serena Gilmore, Shane Poole, et al. · Multiple Sclerosis Journal
Large language models to infer depression in patients with neurological conditions
2026 · Maya Julian-Kwong, Shane Poole, et al. · BMJ Neurology Open
Comparative Effectiveness of Fumarates Versus Sphingosine-1-Phosphate Receptor Modulators in Black Patients with Multiple Sclerosis
2025 · Sophia Woodson, Edward J. Gettings, et al. · Neurology and Therapy
PDF
WeB: A Pilot Study of WEarables for Bladder Monitoring in People with Multiple Sclerosis (S7.009)
2024 · Valerie Block, Anne Suskind, et al. · Neurology
Works count: 29
Citation count: 524
H-index: 9
I10-index: 8
Year
Topic
Type